All Stories

  1. Current and emerging biologics for the treatment of hemophilia

    Article • Expert Opinion on Biological Therapy, April 2019, Taylor & Francis

    Dr Giancarlo Castaman

  2. Advances in diagnosis of von Willebrand disease

    Article • Expert Opinion on Orphan Drugs, April 2019, Taylor & Francis

    Dr Giancarlo Castaman

  3. An international collaborative study to compare different von Willebrand factor glycoprotein Ib binding activity assays: the COMPASS-VWF study

    Article • Journal of Thrombosis and Haemostasis, July 2018, Wiley

    Dr Imre Bodó, Dr Giancarlo Castaman

  4. The benefits of prophylaxis in patients with hemophilia B

    Article • Expert Review of Hematology, July 2018, Taylor & Francis

    Dr Giancarlo Castaman

  5. Comorbidities in persons with haemophilia aged 60 years or more compared with age-matched people from the general population

    Article • Haemophilia, December 2017, Wiley

    Professor Alfonso Iorio, ANTONIO COPPOLA, Dr Giancarlo Castaman

  6. Haematological Care of the Haemophilic Patient

    Article • June 2017, Bentham Science Publishers

    Dr Giancarlo Castaman

  7. Laboratory Aspects

    Article • June 2017, Bentham Science Publishers

    Dr Giancarlo Castaman

  8. Pathogenesis of the Haemophilic Arthropathy

    Article • June 2017, Bentham Science Publishers

    Dr Giancarlo Castaman, Daniela Melchiorre

  9. Pharmacokinetic Approach to the Treatment of Haemophilia

    Article • June 2017, Bentham Science Publishers

    Dr Giancarlo Castaman

  10. Natural history and clinical characteristics of inhibitors in previously treated haemophilia A patients: a case series

    Article • Haemophilia, February 2017, Wiley

    Dr Giancarlo Castaman, Professor Alfonso Iorio

  11. Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A

    Article • Therapeutics and Clinical Risk Management, June 2016, Dove Medical Press

    Dr Giancarlo Castaman

  12. Emerging Issues in Diagnosis, Biology, and Inhibitor Risk in Mild Hemophilia A

    Article • Seminars in Thrombosis and Hemostasis, May 2016, Thieme Publishing Group

    Dr Giancarlo Castaman

  13. Type 2B von Willebrand Disease

    Article • Seminars in Thrombosis and Hemostasis, May 2016, Thieme Publishing Group

    Dr Giancarlo Castaman